Hematologic dysfunction and myeloid neoplasm risk in patients treated with lutetium-177 prostate specific antigen membrane therapy

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2025-04-03
DOI
https://doi.org/10.3324/haematol.2024.286808
Citations
1
Primary Topic
Radiopharmaceutical Chemistry and Applications
Type
article
Field-Weighted Citation Impact
1.36
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hematologic dysfunction and myeloid neoplasm risk in patients treated with lutetium-177 prostate specific antigen membrane therapy

Jaxon Quillen, Daniel S. Childs, Yael N. Kusne, Mrinal M. Patnaik et al.
1 citations
Haematologica
Radiopharmaceutical Chemistry and Applications
1.36
article

Hematologic dysfunction and myeloid neoplasm risk in patients treated with lutetium-177 prostate specific antigen membrane therapy

Jaxon Quillen, Daniel S. Childs, Yael N. Kusne, Mrinal M. Patnaik, Oliver A. Sartor, Osama Mosalem, Geoffrey B. Johnson, Skye Buckner‐Petty, Miguel Muniz
article en
1 citations

Abstract

No abstract available for this paper.
HaematologicaVol. 110(9)
Mayo Clinic in Arizona (US), Mayo Clinic in Florida (US)
Good health and well-being
Openalex Percentile: Top 22%
Radiopharmaceutical Chemistry and Applications
1.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.